JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Interest Income Over TimeExpanding
Percentile Rank100
3Y CAGR+146.3%
5Y CAGR+14.1%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+146.3%/yr
vs -16.9%/yr prior
5Y CAGR
+14.1%/yr
Recent acceleration
Acceleration
+163.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$366.00M+40.2%
2024$261.00M+165.6%
2023$98.28M+301.0%
2022$24.51M-69.7%
2021$80.97M-57.3%
2020$189.46M+72.7%
2019$109.68M+113.8%
2018$51.30M-41.6%
2017$87.79M+220.5%
2016$27.39M-